These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 29017567)

  • 1. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
    Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
    Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.
    Küffer S; Gutting T; Belharazem D; Sauer C; Michel MS; Marx A; Trojan L; Ströbel P
    Mol Oncol; 2018 Feb; 12(2):256-266. PubMed ID: 29239100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
    Baba Y; Nosho K; Shima K; Huttenhower C; Tanaka N; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
    Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
    Watanabe H; Higashimoto K; Miyake N; Morita S; Horii T; Kimura M; Suzuki T; Maeda T; Hidaka H; Aoki S; Yatsuki H; Okamoto N; Uemura T; Hatada I; Matsumoto N; Soejima H
    FASEB J; 2020 Jan; 34(1):960-973. PubMed ID: 31914674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
    Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
    Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
    Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
    Ito Y; Koessler T; Ibrahim AE; Rai S; Vowler SL; Abu-Amero S; Silva AL; Maia AT; Huddleston JE; Uribe-Lewis S; Woodfine K; Jagodic M; Nativio R; Dunning A; Moore G; Klenova E; Bingham S; Pharoah PD; Brenton JD; Beck S; Sandhu MS; Murrell A
    Hum Mol Genet; 2008 Sep; 17(17):2633-43. PubMed ID: 18541649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.
    Nishihara R; Wang M; Qian ZR; Baba Y; Yamauchi M; Mima K; Sukawa Y; Kim SA; Inamura K; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Schernhammer ES
    Am J Clin Nutr; 2014 Dec; 100(6):1479-88. PubMed ID: 25411283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.
    Murrell A; Ito Y; Verde G; Huddleston J; Woodfine K; Silengo MC; Spreafico F; Perotti D; De Crescenzo A; Sparago A; Cerrato F; Riccio A
    PLoS One; 2008 Mar; 3(3):e1849. PubMed ID: 18365005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
    Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
    Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
    Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of
    Damaschke NA; Yang B; Bhusari S; Avilla M; Zhong W; Blute ML; Huang W; Jarrard DF
    Cancer Res; 2017 Oct; 77(19):5236-5247. PubMed ID: 28775169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
    Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
    Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
    Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
    Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.